Clinical Trial Update: Paricalcitol Oral Therapy in Predialysis CKD Patients. The Greek Experience

View source ↗

Summary

This update reports results from a completed clinical trial evaluating oral paricalcitol for predialysis chronic kidney disease patients, including those with s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperparathyroidism

Drugs mentioned

• Zemplar (Paricalcitol)

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Chronic Kidney Failure, Secondary Hyperparathyroidism | Status: COMPLETED | Results posted: 2013-03-07